The Common H202D Variant in GDF-15 Does Not Affect Its Bioactivity but Can Significantly Interfere with Measurement of Its Circulating Levels.
Saved in:
| Title: | The Common H202D Variant in GDF-15 Does Not Affect Its Bioactivity but Can Significantly Interfere with Measurement of Its Circulating Levels. |
|---|---|
| Authors: | Karusheva Y; MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK., Ratcliff M; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK.; Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK., Mörseburg A; MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK., Barker P; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK.; Core Biochemical Assay Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK., Melvin A; MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK., Sattar N; British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK., Burling K; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK.; Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK., Backmark A; Discovery Biology, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Roth R; Discovery Biology, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Jermutus L; Projects, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Guiu-Jurado E; Department for Clinical Obesity Research, Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, Leipzig, Germany., Blüher M; Department for Clinical Obesity Research, Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, Leipzig, Germany., Welsh P; British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK., Hyvönen M; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., O'Rahilly S; MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK. |
| Source: | The journal of applied laboratory medicine [J Appl Lab Med] 2022 Oct 29; Vol. 7 (6), pp. 1388-1400. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101693884 Publication Model: Print Cited Medium: Print ISSN: 2576-9456 (Print) Linking ISSN: 24757241 NLM ISO Abbreviation: J Appl Lab Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35796717 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The Common H202D Variant in GDF-15 Does Not Affect Its Bioactivity but Can Significantly Interfere with Measurement of Its Circulating Levels. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Karusheva+Y%22">Karusheva Y</searchLink>; MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Ratcliff+M%22">Ratcliff M</searchLink>; Biologics Engineering, R&amp;D, AstraZeneca, Cambridge, UK.; Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK.<br /><searchLink fieldCode="AU" term="%22Mörseburg+A%22">Mörseburg A</searchLink>; MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Barker+P%22">Barker P</searchLink>; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK.; Core Biochemical Assay Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.<br /><searchLink fieldCode="AU" term="%22Melvin+A%22">Melvin A</searchLink>; MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Sattar+N%22">Sattar N</searchLink>; British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK.<br /><searchLink fieldCode="AU" term="%22Burling+K%22">Burling K</searchLink>; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK.; Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK.<br /><searchLink fieldCode="AU" term="%22Backmark+A%22">Backmark A</searchLink>; Discovery Biology, Discovery Sciences, Biopharmaceuticals R&amp;D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Roth+R%22">Roth R</searchLink>; Discovery Biology, Discovery Sciences, Biopharmaceuticals R&amp;D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Jermutus+L%22">Jermutus L</searchLink>; Projects, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Guiu-Jurado+E%22">Guiu-Jurado E</searchLink>; Department for Clinical Obesity Research, Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, Leipzig, Germany.<br /><searchLink fieldCode="AU" term="%22Blüher+M%22">Blüher M</searchLink>; Department for Clinical Obesity Research, Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, Leipzig, Germany.<br /><searchLink fieldCode="AU" term="%22Welsh+P%22">Welsh P</searchLink>; British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK.<br /><searchLink fieldCode="AU" term="%22Hyvönen+M%22">Hyvönen M</searchLink>; Biologics Engineering, R&amp;D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22O'Rahilly+S%22">O'Rahilly S</searchLink>; MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101693884%22">The journal of applied laboratory medicine</searchLink> [J Appl Lab Med] 2022 Oct 29; Vol. 7 (6), pp. 1388-1400. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101693884 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>2576-9456 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224757241%22">24757241 </searchLink><i>NLM ISO Abbreviation: </i>J Appl Lab Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35796717 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/jalm/jfac055 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1388 Titles: – TitleFull: The Common H202D Variant in GDF-15 Does Not Affect Its Bioactivity but Can Significantly Interfere with Measurement of Its Circulating Levels. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Karusheva Y – PersonEntity: Name: NameFull: Ratcliff M – PersonEntity: Name: NameFull: Mörseburg A – PersonEntity: Name: NameFull: Barker P – PersonEntity: Name: NameFull: Melvin A – PersonEntity: Name: NameFull: Sattar N – PersonEntity: Name: NameFull: Burling K – PersonEntity: Name: NameFull: Backmark A – PersonEntity: Name: NameFull: Roth R – PersonEntity: Name: NameFull: Jermutus L – PersonEntity: Name: NameFull: Guiu-Jurado E – PersonEntity: Name: NameFull: Blüher M – PersonEntity: Name: NameFull: Welsh P – PersonEntity: Name: NameFull: Hyvönen M – PersonEntity: Name: NameFull: O'Rahilly S IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 10 Text: 2022 Oct 29 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 2576-9456 Numbering: – Type: volume Value: 7 – Type: issue Value: 6 Titles: – TitleFull: The journal of applied laboratory medicine Type: main |
| ResultId | 1 |